respiratory

News

AZ signs pact with mRNA specialists Ethris in respiratory di...

AstraZeneca has signed a five-year strategic research collaboration with Ethris, an mRNA-based therapeutics company specialising in pulmonary disease.

News

Galapagos and FibroGen drugs offer hope in IPF

Drugs improve on existing medicines from Boehringer and Roche.

News

Verona pushes on with COPD drug after £70m fundraiser

UK biotech hopes RPL554 could be a disease modifying drug.

News

Promise of CF combinations lifts Vertex, reignites takeover ...

Encouraging results from three pipeline combination therapies suggests Vertex could extend treatment to patients with more severe and difficult to treat cystic fibrosis.

News